The DOI matches its Crossref record.
Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
Open accessOverview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“by Narasimhan et al. demonstrated that different tau strains isolated from human tauopathy brains were associated with diverse tau neuropathology.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [167]
In the citing paper
“This study revealed that an increase in the tau seeding activity of a particular TauO strain (with high seeding activity), but not others, correlated with worse clinical outcomes in AD patients”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [167]
In the citing paper
“suggesting the existence of TauO strains in different individuals with typical AD.”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [167]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Gaikwad, S., Senapati, S., Haque, M. A., & Kayed, R. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13490 · Cited by 117
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Huang, S., Wang, Y., & Guo, J. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00836-7 · Cited by 63
Jiang, G., Xie, G., Li, X., & Xiong, J. (2025) · Biomolecules · doi:10.3390/biom15060831 · Cited by 48
Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease
Casciano, F., Zauli, E., Celeghini, C., Caruso, L., Gonelli, A., Zauli, G., & Pignatelli, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031689 · Cited by 34
Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11
Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases
Hu, C., Yan, Y., Jin, Y., Yang, J. H., Xi, Y., & Zhong, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01115-9 · Cited by 11
Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo
Yang, Y., Ondrejčák, T., Hu, N., Klyubin, I. V., & Rowan, M. J. (2025) · Molecular Brain · doi:10.1186/s13041-025-01208-8 · Cited by 5
Rate of tau propagation is a heritable disease trait in genetically diverse mouse strains
Welikovitch, L. A., Dujardin, S., Dunn, A. R., Fernandes, A. R., Khasnavis, A., Chibnik, L. B., Kaczorowski, C. C., & Hyman, B. T. (2023) · iScience · doi:10.1016/j.isci.2023.105983 · Cited by 6
Self-citation
Metadata
- Authors
- Dujardin, S., Commins, C., Lathuiliere, A., Beerepoot, P., Fernandes, A. R., Kamath, T. V., De Los Santos, M. B., Klickstein, N., Corjuc, D. L., Corjuc, B. T., Dooley, P. M., Viode, A., Oakley, D. H., Moore, B. D., Mullin, K., Jean-Gilles, D., Clark, R., Atchison, K., Moore, R., Chibnik, L. B., Tanzi, R. E., Frosch, M. P., Serrano-Pozo, A., Elwood, F., Steen, J. A., Kennedy, M. E., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Boston Children's Hospital (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Hyman, Bradley T.
- ORCID
- Venue
- Nature Medicine
- Published
- 2021-01-29
- Volume
- 27
- Issue
- 2
- Pages
- 356-356
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC8363121
- OpenAlex
- W3122053307
- Cited by
- 8
- References
- 0
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2022: 2
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (1RF1AG059789, 1RF1AG058674, 1P30AG062421, 1K08AG064039)
- JPB Foundation
- The Tau consortium
- Alzheimer’s Association (2018-AARF-591935)
- the Martin L. and Sylvia Seevak Hoffman Fellowship for Alzheimer’s research
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2ELP3_184403)
- Cure Alzheimer’s Fund
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, molecular diversity, clinical heterogeneity, Alzheimer's disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
